Rotavirus vaccine and diarrhea mortality: Quantifying regional variation in effect size

BMC Public Health

Volumn 11, Issue SUPPL. 3, 2011, Pages

  Fischer Walker, Christa L ^a   Black, Robert E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

AFRICA; AFRICA SOUTH OF THE SAHARA; ASIA; CHILD; DEVELOPED COUNTRY; DIARRHEA; HOSPITALIZATION; HUMAN; IMMUNOLOGY; META ANALYSIS; MORTALITY; REVIEW; ROTAVIRUS; ROTAVIRUS INFECTION; SOUTH AND CENTRAL AMERICA; VIROLOGY;

AFRICA SOUTH OF THE SAHARA; AFRICA, NORTHERN; ASIA; CHILD; DEVELOPED COUNTRIES; DIARRHEA; HUMANS; LATIN AMERICA; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SEVERITY OF ILLNESS INDEX;

EID: 79954561154     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-S3-S16     Document Type: Review

References (21)

1. Global, regional, and national causes of child mortality in 2008: a systematic analysis. RE Black S Cousens HL Johnson JE Lawn I Rudan DG Bassani P Jha H Campbell CF Walker R Cibulskis,, et al. Lancet 2010 375 9730 1969 1987 10.1016/S0140-6736(10)60549-1 20466419
2. Rotavirus and severe childhood diarrhea. UD Parashar CJ Gibson JS Bresse RI Glass, Emerg Infect Dis 2006 12 2 304 306 16494759
3. The effect of rotavirus vaccine on diarrhoea mortality. MK Munos CL Walker RE Black, Int J Epidemiol 2010 39 Suppl 1 56 62 10.1093/ije/dyq022 20348127
4. Rotavirus vaccine for preventing diarrhoea. K Soares-Weiser E Goldberg G Tamimi OC Pitan L Leibovici, Cochrane Database Syst Rev 2004 1 D002848 14973994
5. Effect of human rotavirus vaccine on severe diarrhea in African infants. SA Madhi NA Cunliffe D Steele D Witte M Kirsten C Louw B Ngwira JC Victor PH Gillard BB Cheuvart,, et al. N Engl J Med 2010 362 4 289 298 10.1056/NEJMoa0904797 20107214
6. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. GE Armah SO Sow RF Breiman MJ Dallas MD Tapia DR Feikin FN Binka AD Steele KF Laserson NA Ansah,, et al. Lancet 2010 376 9741 606 614 10.1016/S0140-6736(10)60889-6 20692030
7. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. K Zaman DA Dang JC Victor S Shin M Yunus MJ Dallas G Podder DT Vu TP Le SP Luby,, et al. Lancet 2010 376 9741 615 623 10.1016/S0140-6736(10)60755-6 20692031
8. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. KB Phua FS Lim YL Lau EA Nelson LM Huang SH Quak BW Lee YL Teoh H Tang I Boudville,, et al. Vaccine 2009 27 43 5936 5941 10.1016/j.vaccine.2009.07.098 19679216
9. Standards for CHERG reviews of intervention effects on child survival. N Walker C Fischer-Walker J Bryce R Bahl S Cousens, Int J Epidemiol 2010 39 Suppl 1 21 31 10.1093/ije/dyq036 20348122
10. Grading quality of evidence and strength of recommendations. D Atkins D Best PA Briss M Eccles Y Falck-Ytter S Flottorp GH Guyatt RT Harbour MC Haugh D Henry,, et al. BMJ 2004 328 7454 1490 10.1136/bmj.328.7454.1490 15205295
11. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. O de Palma L Cruz H Ramos A de Baires N Villatoro D Pastor LH de Oliveira T Kerin M Bowen J Gentsch,, et al. BMJ 2010 340 2825 10.1136/bmj.c2825 20551120
12. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. AC Linhares FR Velazquez I Perez-Schael X Saez-Llorens H Abate F Espinoza P Lopez M Macias-Parra E Ortega-Barria DM Rivera-Medina,, et al. Lancet 2008 371 9619 1181 1189 10.1016/S0140-6736(08)60524-3 18395579 (Pubitemid 351458523)
13. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. T Vesikari A Karvonen R Prymula V Schuster JC Tejedor R Cohen F Meurice HH Han S Damaso A Bouckenooghe, Lancet 2007 370 9601 1757 1763 10.1016/S0140-6736(07)61744-9 18037080 (Pubitemid 350137490)
14. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. T Vesikari DO Matson P Dennehy P Van Damme M Santosham Z Rodriguez MJ Dallas JF Heyse MG Goveia SB Black,, et al. N Engl J Med 2006 354 1 23 33 10.1056/NEJMoa052664 16394299 (Pubitemid 43048948)
15. Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil. TM Lanzieri AC Linhares I Costa DA Kolhe MH Cunha E Ortega-Barria RE Colindres, Int J Infect Dis 2010 21193339
16. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. V Richardson J Hernandez-Pichardo M Quintanar-Solares M Esparza-Aguilar B Johnson CM Gomez-Altamirano U Parashar M Patel, N Engl J Med 2010 362 6 299 305 10.1056/NEJMoa0905211 20107215
17. Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru. CF Lanata K Midthun RE Black B Butron A Huapaya ME Penny G Ventura A Gil M Jett-Goheen BL Davidson, J Infect Dis 1996 174 2 268 275 10.1093/infdis/174.2.268 8699054 (Pubitemid 26251410)
18. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. M Patel C Pedreira LH De Oliveira J Tate M Orozco J Mercado A Gonzalez O Malespin JJ Amador J Umana,, et al. JAMA 2009 301 21 2243 2251 10.1001/jama.2009.756 19491186
19. Rotavirus and the indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting. TL Snelling R Schultz J Graham R Roseby GL Barnes RM Andrews JR Carapetis, Clin Infect Dis 2009 49 3 428 431 10.1086/600395 19566443
20. Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. MM Levine, BMC Biol 2010 8 129 10.1186/1741-7007-8-129 20920375
21. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. JB Correia MM Patel O Nakagomi FM Montenegro EM Germano NB Correia LE Cuevas UD Parashar NA Cunliffe T Nakagomi, J Infect Dis 2010 201 3 363 369 10.1086/649843 20047501